MagForce AG (MagForce AG) Asset Impairment Charge : $0.00 Mil (TTM As of Dec. 2021)

View and export this data going back to 2013. Start your Free Trial

What is MagForce AG Asset Impairment Charge?

MagForce AG's Asset Impairment Charge for the six months ended in Dec. 2021 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2021 was $0.00 Mil.

MagForce AG Asset Impairment Charge Historical Data

The historical data trend for MagForce AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MagForce AG Asset Impairment Charge Chart

MagForce AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Asset Impairment Charge

Get a 7-Day Free Trial

MagForce AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

MagForce AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

MagForce AG Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of MagForce AG's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

MagForce AG (MagForce AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MagForce AG (OTCPK:MGFRF) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Max-Planck-Stresse 3, Berlin, DEU, 12489

Website

https://magforce.de

MagForce AG is a medical engineering company. The company operates in the area of nanotechnology-based cancer treatment. Its medical devices include NanoTherm therapy used for local treatment of solid tumors, NanoTherm a liquid that reacts to the presence of a magnetic field, NanoPlan uses the bioheat transfer equation, and NanoActivator used for tumors in all areas of the body.

MagForce AG (MagForce AG) Headlines

From GuruFocus

MagForce AG Announces Successful Capital Increase Of The Subsidiary MagForce USA, Inc.

By ACCESSWIRE AccessWire • 04-12-2019